Next, we evaluated whether the increase of CH25H mRNA expression is specific to DNMT inhibitors or whether cytotoxic drugs such as cytarabine also induce it, and found that CH25H mRNA expression in MDS-L cells was increased after cytarabine treatment (Fig. 2g). The gene discussed is CH25H; the disease is myelodysplastic syndrome.